SAI - Detailed view

RYZODEG Penfill Inj Lös 5 Patrone 3 ml

Drug

Name

Ryzodeg Penfill, Injektionslösung

Field of application

Diabetes mellitus

ATC

A10AD06 - INSULIN DEGLUDEC AND INSULIN ASPART

07.06.1. – insulin

Use

HAM – Human medicine

pharmaceutical form

LSPA – Parenteral solution

Remedy code

BT – biological medicines

Dispensing categories

B – Dispensed on prescription by a physician or veterinarian (B)

Authorisation status

Z – approved

Authorisation number

62627

Initial registration date

9/12/2013

Expiry date

12/31/9999

Dosage strength

Name

Ryzodeg Penfill, Injektionslösung

Field of application

Diabetes mellitus

Dosage strength number

Authorisation status

Z – approved

Package

GTIN**

7680626270013

Trade status*

In trade from / since 9/12/2013

Status

A/R – Authorised / referenced

Package size

5 x 3 ml

Package code

001

Authorisation status

Z – approved

Declaration

Component

Active substance

420 nmol insulinum degludecum
70 U. insulinum degludecum
180 nmol insulinum aspartum
30 U. insulinum aspartum

Excipient

glycerolum
natrii chloridum
zincum
zinci acetas dihydricus
1.5 mg phenolum
1.72 mg metacresolum
aqua ad iniectabile

Spezialitätenliste***

Status

Date of deletion

Compulsory until

Public price (CHF)

89.90

Limitation points

None

Limitation

SB Deductible

10%

Generic

Authorisation holder

GLN**

7601001001190

Address

Novo Nordisk Pharma AG
8302 Kloten (ZH)

Date of revision of the text

4/29/2025

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.